References
- Akker, S., van den Bijlsma, U. G., Dongen, K., and Ten van Thije, J. H., (1957). The effect of the 3,3,5-trimethylcyclohexanol ester of mandelic acid on artificially produced cardiac infarction and on experimentally produced necrosis of skeletal muscle. Arzneim.-forsch., 7, 15.1. Akker, S., van den Bijlsma, U. G., Dongen, K., and Ten van Thije, J. H., (1957). The effect of the 3,3,5-trimethylcyclohexanol ester of mandelic acid on artificially produced cardiac infarction and on experimentally produced necrosis of skeletal muscle. Arzneim.-forsch., 7, 15.
- Bijlsma, U. G., Funcke, A. B. H., Tersteege, H. M., Rekker, R. F., Ernsting, M. J. E., and Nauta, W. Th., (1956). The pharmacology of Cyclospasmol. Arch. int. Pharmacodyn, 105, 145.2. Bijlsma, U. G., Funcke, A. B. H., Tersteege, H. M., Rekker, R. F., Ernsting, M. J. E., and Nauta, W. Th., (1956). The pharmacology of Cyclospasmol. Arch. int. Pharmacodyn, 105, 145.
- Funcke, A. B. H., (1952). Pharmacological investigations on the spasmolytic activity of a series of mandelic acid esters, especially the ester of 3,3,5-trimethylcyclohexanol (Cyclospasmol). Thesis, Vrije Universiteit, Amsterdam.3. Funcke, A. B. H., (1952). Pharmacological investigations on the spasmolytic activity of a series of mandelic acid esters, especially the ester of 3,3,5-trimethylcyclohexanol (Cyclospasmol). Thesis, Vrije Universiteit, Amsterdam.
- Kappert, A., (1955). Die Behandlung peripherer Durchblutungsstörungen mit Cyclospasmol. Schweiz med. Wschr., 85, 237.4. Kappert, A., (1955). Die Behandlung peripherer Durchblutungsstörungen mit Cyclospasmol. Schweiz med. Wschr., 85, 237.
- Leibetseder, F., (1953). Zur Behandlung von Durchblutungsstorungen. Wien. med. Wschr., 103, 556.5. Leibetseder, F., (1953). Zur Behandlung von Durchblutungsstorungen. Wien. med. Wschr., 103, 556.